Clinical Trial Update: Effect of Arabinoxylan and Rye Kernels on Second Meal Responses [NA]

View source ↗

Summary

The Aarhus University Hospital-sponsored trial evaluating arabinoxylan and rye kernels on second-meal responses in people with metabolic syndrome has completed.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: Aarhus University Hospital | Conditions: Metabolic Syndrome | NA | Status: COMPLETED